Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/ENGN/Net margin

enGene Therapeutics Inc. (ENGN) Net margin

enGene Therapeutics Inc. (ENGN) net profit margin by fiscal year — reported net income divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to ENGN

Source: SEC XBRL filings · For reference only · Not investment advice

More ENGN financial trends

ENGN RevenueENGN Net incomeENGN Gross profitENGN Gross marginENGN Operating incomeENGN Operating marginENGN Operating cash flowENGN Free cash flowENGN Capital expendituresENGN Return on equityENGN Stock buybacksENGN Dividends paidENGN Total assetsENGN Total liabilitiesENGN Shareholders’ equityENGN overview →